Cemex Shares Popped: What You Need to Know

Updated

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of global cement giant Cemex (NYS: CX) were looking uncharacteristically solid today, soaring as much as 27% in intraday trading on hopes that European efforts will stem the region's fiscal crisis.

So what: For Mexico-based Cemex, North America is the largest lever for performance, with hefty chunks of business in Mexico and the United States. However, roughly a third of the company's revenue comes from Europe. As the company struggles under a massive, threatening debt load, it really can't afford to have any major region suffering. Since a solution -- or at least the avoidance of total disaster -- in Europe could mean better times ahead in that region, good news for the EU is good news for Cemex.

Now what: Over the summer I recommended Cemex as part of one of my bargain-bin baskets. That thumbs-up was based on the fact that there is a real business here, the stock looks very cheap, and if the company doesn't collapse under the weight of its debt, the stock could see serious gains. But it's also not a stock that I'd recommend putting any serious amount of money into or bothering with at all if you're risk-averse and looking for solid, long-term holdings.

Want to keep up to date on Cemex?Add it to your watchlist.

At the time thisarticle was published Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.Fool contributorMatt Koppenhefferowns shares of Cemex but has no financial interest in any of the other companies mentioned. You can check out what Matt is keeping an eye on by visiting hisCAPS portfolio, or you can follow Matt on Twitter,@KoppTheFool, or onFacebook. The Fool'sdisclosure policyprefers dividends over a sharp stick in the eye.

Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement